{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:30Z","timestamp":1786988070023,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA133791"],"award-info":[{"award-number":["R01CA133791"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011132","name":"Rutgers University","doi-asserted-by":"publisher","award":["TA2019-0300"],"award-info":[{"award-number":["TA2019-0300"]}],"id":[{"id":"10.13039\/100011132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejmech.2023.116104","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T21:34:15Z","timestamp":1703626455000},"page":"116104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Structural modification of C2-substituents on 1,4-bis(arylsulfonamido)benzene or naphthalene-N,N\u2032-diacetic acid derivatives as potent inhibitors of the Keap1-Nrf2 protein-protein interaction"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2257-0798","authenticated-orcid":false,"given":"Sumi","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1719-6199","authenticated-orcid":false,"given":"Ahmed R.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-9602","authenticated-orcid":false,"given":"Dhulfiqar Ali","family":"Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0936-2019","authenticated-orcid":false,"given":"Mai-Uyen","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-4330","authenticated-orcid":false,"given":"Michael P.","family":"Verzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1799-5652","authenticated-orcid":false,"given":"Longqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.116104_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","article-title":"Oxidative stress and antioxidant defense","volume":"5","author":"Birben","year":"2012","journal-title":"World Allergy Organ. J."},{"key":"10.1016\/j.ejmech.2023.116104_bib2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1\u2013Nrf2\u2013ARE pathway as a potential preventive and therapeutic target: an Update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2023.116104_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/med.21257","article-title":"Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents","volume":"32","author":"Magesh","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2023.116104_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1089\/ars.2010.3221","article-title":"Cancer chemoprevention mechanisms mediated through the Keap1\u2013Nrf2 pathway","volume":"13","author":"Hayes","year":"2010","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.ejmech.2023.116104_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2023.116104_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00204-011-0674-5","article-title":"The cytoprotective role of the Keap1\u2013Nrf2 pathway","volume":"85","author":"Baird","year":"2011","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2023.116104_bib7","first-page":"S128","article-title":"Direct and indirect antioxidant properties of inducers of cytoprotective proteins","volume":"52","author":"Dinkova-Kostova","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejmech.2023.116104_bib8","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","article-title":"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region","volume":"91","author":"Moi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2023.116104_bib9","doi-asserted-by":"crossref","first-page":"11908","DOI":"10.1073\/pnas.172398899","article-title":"Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants","volume":"99","author":"Dinkova-Kostova","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2023.116104_bib10","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","article-title":"Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex","volume":"24","author":"Zhang","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.116104_bib11","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.116104_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/tx700302s","article-title":"Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3","volume":"21","author":"Rachakonda","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2023.116104_bib13","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1128\/MCB.00753-07","article-title":"Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response","volume":"27","author":"Tong","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.116104_bib14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.biotechadv.2014.03.004","article-title":"Monitoring Keap1\u2013Nrf2 interactions in single live cells","volume":"32","author":"Baird","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2023.116104_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/MCB.26.1.221-229.2006","article-title":"Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1","volume":"26","author":"Kobayashi","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.116104_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.taap.2009.06.009","article-title":"Nrf2 signaling and cell survival","volume":"244","author":"Niture","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.116104_bib17","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.12688\/f1000research.12111.1","article-title":"Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate","volume":"6","author":"Satoh","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.ejmech.2023.116104_bib18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2023.116104_bib19","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1681\/ASN.2012050457","article-title":"Bardoxolone methyl decreases megalin and activates Nrf2 in the kidney","volume":"23","author":"Reisman","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2023.116104_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.29286","article-title":"Efficacy of omaveloxolone in friedreich's ataxia: delayed-start analysis of the MOXIe extension","volume":"38","author":"Lynch","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejmech.2023.116104_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cbpa.2010.12.009","article-title":"Small molecule modulators of antioxidant response pathway","volume":"15","author":"Hur","year":"2011","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.116104_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120254","article-title":"Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro","volume":"10","author":"Brennan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.116104_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098896","article-title":"Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO","volume":"9","author":"Cleasby","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.116104_bib24","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"De Zeeuw","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2023.116104_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.846152","article-title":"Molecular and cellular mechanisms underlying the initiation and progression of Alport glomerular pathology","volume":"9","author":"Cosgrove","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2023.116104_bib26","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.116104_bib27","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.bmcl.2015.04.019","article-title":"Non-electrophilic modulators of the canonical Keap1\/Nrf2 pathway","volume":"25","author":"Richardson","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.116104_bib28","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/j.bmcl.2013.03.013","article-title":"Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction","volume":"23","author":"Hu","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.116104_bib29","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","article-title":"Monoacidic inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein\u2013protein interaction with high cell potency identified by fragment-based discovery","volume":"59","author":"Davies","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115343","article-title":"Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction","volume":"28","author":"Abed","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib31","doi-asserted-by":"crossref","first-page":"14481","DOI":"10.1021\/acs.jmedchem.2c00830","article-title":"Development of noncovalent small-molecule Keap1-Nrf2 inhibitors by fragment-based drug discovery","volume":"65","author":"Narayanan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib32","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/jm5000529","article-title":"Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis","volume":"57","author":"Jiang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2015.08.049","article-title":"Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators","volume":"103","author":"Jain","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116300","article-title":"Optimization of 1,4-bis(arylsulfonamido)naphthalene-N,N'-diacetic acids as inhibitors of Keap1-Nrf2 protein-protein interaction to suppress neuroinflammation","volume":"44","author":"Abed","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114380","article-title":"Structure-activity relationships of 1,4-bis(arylsulfonamido)-benzene or naphthalene-N,N\u2032-diacetic acids with varying C2-substituents as inhibitors of Keap1-Nrf2 protein-protein interaction","volume":"237","author":"Lee","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115302","article-title":"Optimization of the C2 substituents on the 1,4-bis(arylsulfonamido)naphthalene-N,N\u2032-diacetic acid scaffold for better inhibition of Keap1-Nrf2 protein-protein interaction","volume":"252","author":"Abed","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib37","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1021\/acs.jmedchem.2c00457","article-title":"Phenyl bis-sulfonamide Keap1-Nrf2 protein\u2013protein interaction inhibitors with an alternative binding mode","volume":"65","author":"Georgakopoulos","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib38","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00044-020-02539-y","article-title":"Nrf2 activation through the inhibition of Keap1\u2013Nrf2 protein\u2013protein interaction","volume":"29","author":"Lee","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.116104_bib39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/adsc.200600469","article-title":"Formation of arenes via diallylarenes: strategic utilization of Suzuki\u2013Miyaura cross\u2010coupling, Claisen rearrangement and ring\u2010closing metathesis","volume":"349","author":"Kotha","year":"2007","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2023.116104_bib40","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1021\/ol9004118","article-title":"A tandem conjugate addition\/cyclization protocol for the asymmetric synthesis of 2-aryl-4-aminotetrahydroquinoline-3-carboxylic acid derivatives","volume":"11","author":"Davies","year":"2009","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2023.116104_bib41","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1016\/j.bmcl.2016.10.083","article-title":"Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity","volume":"26","author":"Yasuda","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.116104_bib42","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1021\/jo900600m","article-title":"Copper(I)-catalyzed aryl bromides to form intermolecular and intramolecular carbon\u2212oxygen bonds","volume":"74","author":"Niu","year":"2009","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1087057111430124","article-title":"Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction","volume":"17","author":"Inoyama","year":"2012","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2023.116104_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/2472555220935816","article-title":"Development of a homogeneous time-resolved fluorescence resonance energy transfer (TR-FRET) assay for the inhibition of Keap1\u2013Nrf2 protein\u2013protein interaction","volume":"26","author":"Lee","year":"2020","journal-title":"SLAS Dis."},{"key":"10.1016\/j.ejmech.2023.116104_bib45","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2023.116104_bib46","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423010711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423010711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T09:54:44Z","timestamp":1736848484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423010711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":46,"alternative-id":["S0223523423010711"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116104","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural modification of C2-substituents on 1,4-bis(arylsulfonamido)benzene or naphthalene-N,N\u2032-diacetic acid derivatives as potent inhibitors of the Keap1-Nrf2 protein-protein interaction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116104"}}